PostEra is using our Protonplatform to develop cures for diseases via an internal drug discovery pipeline and also through co-discovery with pharma partners.

Biopharma partner selects biological targets and helps define the assay cascade and Target-Product-Profile.

PostEra drives the discovery of safe and effective small molecules against those targets until the nomination of Development Candidate(s).

The Partner and PostEra agree on who shall sponsor the asset into IND-enabling studies and the Clinic.